In California, a new report “Analysis of Biomedical Textiles Market in U.S.” from Frost & Sullivan’s Visionary Science Team predicts a growth in the use of biomaterials, especially those that biodegrade, in medical device implants. The report notes that with an increasing geriatric population who are more likely to have chronic illnesses and longer recovery times, this is a huge step forward as they will now be less likely to need a second surgery to remove implants. The increases in demand for biodegradable implants are leading to more market innovation and new product launches to improve upon existing technologies and biomaterial applications. Some companies that are leading this work right now to keep an eye on include Boston Scientific, CR Bard, Smith and Nephew, Medtronic and Edwards Lifesciences.
